PDF herunterladen
Schlaf 2016; 05(04): 200-204
DOI: 10.1055/s-0038-1624996
Kasuistik
Schattauer GmbH

Odyssee oder Punkt landung?

Dagmar Norden
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
12. Februar 2018 (online)

    Lizenzen und Reprints

Kombinationstherapien spielen eine wesentliche Rolle bei der effektiven Behandlung des OSAS. Die Behandlung mit einer Unterkieferprotrusionsschiene bietet eine Alternative zu Maskentherapie bei obstruktiver Schlafapnoe. Die Effektivität variiert interindividuell zwar stärker, dafür wird die Schiene besser von den Patienten akzeptiert.

 

  • Literatur

  • 1 Ramar K. et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med 2015; 11 (07) 773-827.
    CrossrefPubMedGoogle Scholar
  • 2 Kribbs NB, Pack AI, Kline LR. et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 147 (04) 887-895.
    CrossrefPubMedGoogle Scholar
  • 3 Bamagoos AA, Sutherland K, Cistulli PA. Mandibular Advancement Splints. Sleep Med Clin 2016; 11 (03) 343-52.
    CrossrefPubMedGoogle Scholar
  • 4 Okuno K, Pliska BT, Hamoda M. et al. Prediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review. Sleep Med Rev 2015; 8 (30) 25-33.
    Google Scholar
  • 5 Sutherland K, Takaya H, Qian J. et al. Oral appliance treatment response and polysomnographic phenotypes of obstructive sleep apnea. J Clin Sleep Med 2015; 11 (08) 861-8.
    PubMedGoogle Scholar
  • 6 Johal A, Battagel JM, Kottecha BT. Sleep nasendoscopy: a diagnostic tool for prediciting treatment success with mandibular advancement splints in obstructive sleep apnea. Eur J Orthod 2005; 27 (06) 607-614.
    CrossrefPubMedGoogle Scholar
  • 7 Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral appliance therapy improves symptoms in in obstructive sleep apnea: a randomized, controlled trial. Am j Respir Crit Care Med 2002; 166 (05) 743-748.
    CrossrefPubMedGoogle Scholar
  • 8 Mehta A, Qian j, Petocz P. et al. A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med 2001; 163 (06) 1457-1461.
    CrossrefPubMedGoogle Scholar
  • 9 Deacon NL, Jen R, Li Y, Malhotra A. treatment of obstrucitve sleep apnea. Prospects for personalized combined modality therapy. Ann Am Thorac Soc 2016; 13 (01) 101-108.
    CrossrefPubMedGoogle Scholar
  • 10 Chan AS, Lee RW, Srinivasan VK. et al. Nasopharyngoscopic evaluation of oral appliance therapy for obstructive sleep apnea. Eur Respir J 2010; 35 (04) 836-842.
    CrossrefPubMedGoogle Scholar
  • 11 Walters AS, Winkelmann J, Trenkwalder C, Fry JM, Kataria V, Wagner M, Sharma R, Hening W, Li L. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord 2001; 16 (06) 1105-1109.
    CrossrefPubMedGoogle Scholar
  • 12 Van Ryswyk E, Antic N. Opioids and sleep disordered breathing. Chest 2016; Jun 1. pii S0012-3692 (16) 49109-9. [Epub ahead of print]
    Google Scholar
  • 13 Petit FX, Pepin JL, Bettega G, Sadek H, Raphael B, Levy P. Mandibular advancement devices: rate of contraindications in 100 consecutive obstructive sleep apnea patients. Am J Respir Crit Care Med 2002; 166(§): 274-278.
    CrossrefPubMedGoogle Scholar
  • 14 Battagel JM, Kotecha B. Dental side-effects of mandibular advancement splint wear in patients who snore. Clin otolaryngol 2005; 30: 149-156.
    CrossrefPubMedGoogle Scholar